A detailed history of Allegheny Financial Group LTD transactions in Precigen, Inc. stock. As of the latest transaction made, Allegheny Financial Group LTD holds 17,065 shares of PGEN stock, worth $78,669. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,065
Previous 54,130 68.47%
Holding current value
$78,669
Previous $76,000 26.32%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$1.43 - $4.76 $53,002 - $176,429
-37,065 Reduced 68.47%
17,065 $56,000
Q4 2024

Feb 14, 2025

BUY
$0.67 - $1.12 $36,267 - $60,625
54,130 New
54,130 $60,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Allegheny Financial Group LTD Portfolio

Follow Allegheny Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allegheny Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Allegheny Financial Group LTD with notifications on news.